The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial
Open accessAbstract
Background: Severe traumatic brain injury (TBI) has been increasing with greater incidence of injuries from traffic or sporting accidents. Although there are a number of animal models of TBI using progesterone for head injury, the effects of progesterone on neurologic outcome of acute TBI patients remain unclear. The aim of the present clinical study was to assess the longer-term efficacy of progesterone on the improvement in neurologic outcome of patients with acute severe TBI. Methods: A total of 159 patients who arrived within 8 hours of injury with a Glasgow Coma Score ≤ 8 were enrolled in the study. A prospective, randomized, placebo-controlled trial of progesterone was conducted in the Neurotrauma Center of our teaching hospital. The patients were randomized to receive either progesterone or placebo. The primary endpoint was the Glasgow Outcome Scale score 3 months after brain injury. Secondary efficacy endpoints included the modified Functional Independence Measure score and mortality. In a follow-up protocol at 6 months, the Glasgow Outcome Scale and the modified Functional Independence Measure scores were again determined. Results: Of the 159 patients randomized, 82 received progesterone and 77 received placebo. The demographic characteristics, the mechanism of injury, and the time of treatment were compared for the two groups. After 3 months and 6 months of treatment, the dichotomized Glasgow Outcome Scale score analysis exhibited more favorable outcomes among the patients who were given progesterone compared with the control individuals ( P = 0.034 and P = 0.048, respectively). The modified Functional Independence Measure scores in the progesterone group were higher than those in the placebo group at both 3-month and 6-month follow-up ( P < 0.05 and P < 0.01). The mortality rate of the progesterone group was significantly lower than that of the placebo group at 6-month follow-up ( P < 0.05). The mean intracranial pressure values 72 hours and 7 days after injury were lower in the progesterone group than in the placebo group, but there was no statistical significance between the two groups ( P > 0.05). Instances of complications and adverse events associated with the administration of progesterone were not found. Conclusion: Our data suggest that acute severe TBI patients with administration of progesterone hold improved neurologic outcomes for up to 6 months. These results provide information important for further large and multicenter clinical trials on progesterone as a promising neuroprotective drug. Trial Registration: ACTRN12607000545460.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Basic and Clinical Pharmacology
Katzung, B. G. (1982) · Andalas University Repository (Andalas University) · Cited by 1,914
Basic and clinical pharmacology
Traynor, J. R. (1988) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/0731-7085(88)80021-9 · Cited by 1,126
ROOF, R. L., & HALL, E. D. (2000) · Journal of Neurotrauma · doi:10.1089/neu.2000.17.367 · Cited by 655
ProTECT: A Randomized Clinical Trial of Progesterone for Acute Traumatic Brain Injury
Wright, D. W., Kellermann, A. L., Hertzberg, V. S., Clark, P. L., Frankel, M., Goldstein, F. C., Salomone, J. P., Dent, L. L., Harris, O. A., Ander, D. S., et al. (2007) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2006.07.932 · Cited by 595
Leker, R. R., & Shohami, E. (2002) · Brain Research Reviews · doi:10.1016/s0165-0173(02)00157-1 · Cited by 409
Djebaili, M., Guo, Q., Pettus, E. H., Hoffman, S. W., & Stein, D. G. (2005) · Journal of Neurotrauma · doi:10.1089/neu.2005.22.106 · Cited by 386
Gender influences outcome of brain injury: progesterone plays a protective role
Roof, R. L., Duvdevani, R., & Stein, D. G. (1993) · Brain Research · doi:10.1016/0006-8993(93)91526-x · Cited by 326
Roof, R. L., Duvdevani, R., Braswell, L., & Stein, D. G. (1994) · Experimental Neurology · doi:10.1006/exnr.1994.1147 · Cited by 321
Progesterone protects against lipid peroxidation following traumatic brain injury in rats
Roof, R. L., Hoffman, S. W., & Stein, D. G. (1997) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815156 · Cited by 316
Mosenthal, A. C., Livingston, D. H., Lavery, R. F., Knudson, M. M., Lee, S., Morabito, D., Manley, G. T., Nathens, A., Jurkovich, G., Hoyt, D. B., et al. (2004) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/01.ta.0000127767.83267.33 · Cited by 305
Cited by
Neuroinflammation after traumatic brain injury: Opportunities for therapeutic intervention
Kumar, A., & Loane, D. J. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.06.008 · Cited by 710
Loane, D. J., & Faden, A. I. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.09.005 · Cited by 574
Very Early Administration of Progesterone for Acute Traumatic Brain Injury
Wright, D. W., Yeatts, S. D., Silbergleit, R., Palesch, Y. Y., Hertzberg, V. S., Frankel, M., Goldstein, F. C., Caveney, A. F., Howlett-Smith, H., Bengelink, E. M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1404304 · Cited by 567
Bramlett, H. M., & Dietrich, W. D. (2015) · Journal of Neurotrauma · doi:10.1089/neu.2014.3352 · Cited by 550
Sex differences in cognitive impairment and Alzheimer’s disease
Li, R., & Singh, M. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.01.002 · Cited by 527
Traumatic brain injury in China
Jiang, J.-Y., Gao, G.-Y., Feng, J.-F., Mao, Q., Chen, L.-G., Yang, X.-F., Liu, J.-F., Wang, Y.-H., Qiu, B.-H., & Huang, X.-J. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30469-1 · Cited by 515
A Clinical Trial of Progesterone for Severe Traumatic Brain Injury
Skolnick, B. E., Maas, A. I., Narayan, R. K., van der Hoop, R. G., MacAllister, T., Ward, J. D., Nelson, N. R., & Stocchetti, N. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1411090 · Cited by 505
Recent advances in traumatic brain injury
Khellaf, A., Khan, D. Z., & Helmy, A. (2019) · Journal of Neurology · doi:10.1007/s00415-019-09541-4 · Cited by 485
Muneer, P. M. A., Chandra, N., & Haorah, J. (2015) · Molecular Neurobiology · doi:10.1007/s12035-014-8752-3 · Cited by 459
Stanczyk, F. Z., Hapgood, J. P., Winer, S., & Mishell, D. R. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1008 · Cited by 429
Sex Differences in Outcome after Mild Traumatic Brain Injury
Bazarian, J. J., Blyth, B., Mookerjee, S., He, H., & McDermott, M. P. (2010) · Journal of Neurotrauma · doi:10.1089/neu.2009.1068 · Cited by 371
Schumacher, M., Mattern, C., Ghoumari, A., Oudinet, J. P., Liere, P., Labombarda, F., Sitruk-Ware, R., De Nicola, A. F., & Guennoun, R. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.09.004 · Cited by 355
Clinical trials in traumatic brain injury: past experience and current developments
Maas, A. I. R., Roozenbeek, B., & Manley, G. T. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2009.10.022 · Cited by 291
Diaz-Arrastia, R., Kochanek, P. M., Bergold, P., Kenney, K., Marx, C. E., Grimes, C. J. B., Loh, L. Y., Adam, L. G. E., Oskvig, D., Curley, K. C., et al. (2014) · Journal of Neurotrauma · doi:10.1089/neu.2013.3019 · Cited by 262
Vitamin D as a neurosteroid affecting the developing and adult brain
Groves, N. J., McGrath, J. J., & Burne, T. H. J. (2014) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071813-105557 · Cited by 256
150 Years of Treating Severe Traumatic Brain Injury: A Systematic Review of Progress in Mortality
Stein, S. C., Georgoff, P., Meghan, S., Mizra, K., & Sonnad, S. S. (2010) · Journal of Neurotrauma · doi:10.1089/neu.2009.1206 · Cited by 255
Embracing failure: What the Phase III progesterone studies can teach about TBI clinical trials
Stein, D. G. (2015) · Brain Injury · doi:10.3109/02699052.2015.1065344 · Cited by 249
Neuroprotective strategies for retinal disease
Pardue, M. T., & Allen, R. S. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2018.02.002 · Cited by 237
“However, while the literature supporting progesterone's protective effects in animal research and Phase II clinical trials (Wright et al., 2007; Xiao et al., 2008) is vast, two Phase III clinical trials testing progesterone treatment in traumatic brain injury failed to show an effect (Skolnick et al.”
Marx, C. E., Keefe, R. S. E., Buchanan, R. W., Hamer, R. M., Kilts, J. D., Bradford, D. W., Strauss, J. L., Naylor, J. C., Payne, V. M., Lieberman, J. A., et al. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.26 · Cited by 193
Acute Serum Hormone Levels: Characterization and Prognosis after Severe Traumatic Brain Injury
Wagner, A. K., McCullough, E. H., Niyonkuru, C., Ozawa, H., Loucks, T. L., Dobos, J. A., Brett, C. A., Santarsieri, M., Dixon, C. E., Berga, S. L., et al. (2011) · Journal of Neurotrauma · doi:10.1089/neu.2010.1586 · Cited by 172
A review of neuroprotection pharmacology and therapies in patients with acute traumatic brain injury
McConeghy, K. W., Hatton, J., Hughes, L., & Cook, A. M. (2012) · CNS Drugs · doi:10.2165/11634020-000000000-00000 · Cited by 158
El-Etr, M., Rame, M., Boucher, C., Ghoumari, A. M., Kumar, N., Liere, P., Pianos, A., Schumacher, M., & Sitruk-Ware, R. (2015) · Glia · doi:10.1002/glia.22736 · Cited by 116
Gobinath, A. R., Choleris, E., & Galea, L. A. M. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.23872 · Cited by 87
Gruenbaum, S. E., Zlotnik, A., Gruenbaum, B. F., Hersey, D., & Bilotta, F. (2016) · CNS Drugs · doi:10.1007/s40263-016-0355-2 · Cited by 86
“Two small RCTs clearly demonstrated improved outcomes with progesterone administration after TBI, which subsequently paved the way for larger RCTs [59, 60].”
BackgroundGender impacts mortality after traumatic brain injury in teenagers
Ley, E. J., Short, S. S., Liou, D. Z., Singer, M. B., Mirocha, J., Melo, N., Bukur, M., & Salim, A. (2013) · Journal of Trauma and Acute Care Surgery · doi:10.1097/ta.0b013e31829d024f · Cited by 74
Progesterone protects mitochondrial function in a rat model of pediatric traumatic brain injury
Robertson, C. L., & Saraswati, M. (2015) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-014-9585-5 · Cited by 56
Wagner, A. K., Brett, C. A., McCullough, E. H., Niyonkuru, C., Loucks, T. L., Dixon, C. E., Ricker, J., Arenth, P., & Berga, S. L. (2012) · Brain Injury · doi:10.3109/02699052.2012.667594 · Cited by 47
Tsai, Y.-T., Wang, C.-C., Leung, P.-O., Lin, K.-C., Chio, C.-C., Hu, C.-Y., & Kuo, J.-R. (2014) · Journal of Surgical Research · doi:10.1016/j.jss.2014.02.009 · Cited by 25
Combination therapies for traumatic brain injury: prospective considerations
Margulies, S. S., & Hicks, R. (2009) · Journal of Neurotrauma · doi:10.1089/neu.2008-0794 · Cited by 22
Metadata
- Authors
- Xiao, G., Wei, J., Yan, W., Wang, W., & Lu, Z.
- Venue
- Critical Care
- Published
- 2008-04-30
- Volume
- 12
- Issue
- 2
- Pages
- R61-R61
- ISSN
- 1364-8535 (ISSN-L)
- OpenAlex
- W1987111435
- Cited by
- 461
- References
- 30
- FWCI
- 18.27
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.